Medtronic Cardiovascular Chief Coyle To Lead iRhythm
Executive Summary
Sean Salmon, the head of Medtronic’s diabetes business, will take over the leadership of the company’s cardiovascular business effective 1 January.
You may also be interested in...
Que Dallara Takes Over Medtronic Diabetes At A Critical Moment
Dallara is joining Medtronic from Honeywell, where she served as CEO of the conglomerate’s Connected Enterprise. The company also promoted Mike Marinaro to the president of Medtronic’s surgical robotics unit and Kweli Thomson to lead the cardiac rhythm management unit.
Mike Coyle Steps Down As iRhythm CEO; CFO Douglas Devine Will Be Interim CEO
Douglas Devine will take over as interim CEO as iRhythm tries to resolve reimbursement challenges and roll out the next generation of its Zio remote cardiac monitor with an updated artificial intelligence system.
Cardiac Monitoring Companies Fight Medicare Reimbursement Cut By Novitas
Medicare carrier Novitas has proposed to cut reimbursement for long-term electrocardiogram monitoring, which could be a major headache for companies like iRhythm.